Real-world evidence of Trastuzumab Deruxtecan (T-DXd) Efficacy in HER2-expressing gynecological malignancies. Andrikopoulou A, Zagouri F, Goula K, Haidopoulos D, et al. BMC Cancer 2024;24:1503.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Andrikopoulou A, Zagouri F, Goula K, Haidopoulos D, et al. Real-world evidence of Trastuzumab Deruxtecan (T-DXd) Efficacy in HER2-expressing gynecological malignancies. BMC Cancer 2024;24:1503.
PMID: 39639215